Unicondylar Knee Arthroplasty Versus Total Knee Arthroplasty in Patients With Anteromedial Osteoarthritis of the Knee

Summary

Participation Requirements

Description

Title: Unicondylar knee arthroplasty versus total knee arthroplasty in patients with anteromedial osteoarthritis of the knee. Rationale: Unicompartmental knee arthroplasty (UKA) offers several possible advantages over total knee arthroplasty (TKA). One important possible advantage is overall higher ...

Title: Unicondylar knee arthroplasty versus total knee arthroplasty in patients with anteromedial osteoarthritis of the knee. Rationale: Unicompartmental knee arthroplasty (UKA) offers several possible advantages over total knee arthroplasty (TKA). One important possible advantage is overall higher patient satisfaction with UKA. Patients have superior post-operative range of motion and a more "natural-feeling" knee. Previously, patients with patellofemoral joint osteoarthritis (PFJOA) were excluded from UKA. However, recent studies suggest that excellent results can be achieved with UKA despite pre-existing moderate PFJOA. This may broaden pre-defined inclusion criteria for UKA. To date, no biomechanical studies directly comparing UKA and TKA have been performed. Biomechanical data could help explain outcome differences. This study aims to compare both clinical and biomechanical outcomes in patients receiving UKA versus TKA for anteromedial OA in the presence of no to moderate PFJOA. Hypothesis: We hypothesize that post-operative UKA patients will display higher clinical scores using WOMAC and OKS questionnaires, and superior biomechanical analysis measures. In comparing to healthy controls, we expect to see UKA patients perform more closely to controls than TKA patients, with regards to WOMAC, OKS, and biomechanical scores. We further hypothesize that UKA patients will have larger changes in WOMAC and OKS scores pre- to post-operatively than TKA patients. Study design: This study is a randomized controlled trial. Eligible patients have: anteromedial compartment osteoarthritis (OA) with intact anterior cruciate ligament (ACL) by clinical testing and alignment on radiographs; normal or mild to moderate PFJOA; angular deformity <15 degrees passively correctible to neutral; flexion contracture<5 degrees; BMI<40; age 40-80 years. We exclude patients with: severe PFJOA; history of previous surgery on the affected knee (excluding simple meniscectomy); inflammatory arthropathy; previous contralateral knee replacement surgery or major ligament reconstruction surgery. Patients will be stratified based on their PFJOA status. They will be randomized using StudyTRAX (ScienceTrax, Macon, GA) online system to one of two treatment arms: UKA (n=19) or TKA (n=19). The control group will be matched to study group characteristics, and recruited through University of Calgary and Alberta Hip and Knee Clinic (AHKC). UKA patients will receive a mobile bearing, Oxford UKA (Biomet, Warsaw, IN) utilizing microplasty instrumentation. TKA patients will receive a posterior cruciate-retaining TKA with unresurfaced patella utilizing Persona instrumentation (Zimmer, Warsaw, IN). Clinical outcomes will be assessed pre-operatively, and post-operatively at 6 weeks, 3 months, 1 year, and 2 years utilizing the WOMAC and OKS questionnaires. Radiographs include weight bearing anteroposterior (AP), AP, lateral and skyline views, and valgus stress views. These are standard to treatment at AHKC, and will be taken preoperatively and at the 2 day (non-weightbearing views only), 3 month, and 1 year postoperative appointments. Interpretation will be by the treating surgeons.Biomechanical assessment will include gait analysis and electromyography (EMG), and will be done at the Clinical Movement Analysis Laboratory (CMAL) at the McCaig Institute. This will be measured pre-operatively and at one year post-operatively. A healthy, age, gender and weight matched control group will be recruited to establish deviations of the patient groups from the healthy norm. Clinical and biomechanical outcomes will be assessed only once for the control group. The analysis plan includes descriptive analyses, univariate analysis to explore between-group differences and repeated-measures ANOVA to assess statistically significant changes in WOMAC, OKS, and biomechanical outcomes over time within both groups. T-test & Pearson chi-square test will be computed for all continuous variables and categorical variables, accordingly. A multivariate linear regression analysis may be performed to reveal relationships between variables, enabling us to control for baseline variables of interest. Significance of work: No studies to date have investigated whether UKA or TKA is favorable in patients with no to moderate PFJOA, but who meet all other traditional criteria for UKA. Additionally, no biomechanical data exists in this area. If patients receiving UKA demonstrate similar (or better) clinical and biomechanical outcomes to those receiving TKA, then it would suggest that UKA could be offered to a much greater number of patients, as a less invasive procedure, with potential health system savings. It is anticipated that the biomechanical data, in combination with the clinical research data, will help to better understand the differences between these two surgical approaches.

Tracking Information